Davood Bashash
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Hematology top 5%
- Acute Myeloid Leukemia Research
Papers in
-
- Retinoids in leukemia and cellular processes 28
- PI3K/AKT/mTOR signaling in cancer 21
- Protein Degradation and Inhibitors 11
- Histone Deacetylase Inhibitors Research 10
- Oncology 51
- Cancer Immunotherapy and Biomarkers 14
- Co-authors
- Atieh Pourbagheri‐Sigaroodi (58 shared papers)Seyed H. Ghaffari (57 shared papers)Ava Safaroghli‐Azar (42 shared papers)Hassan Abolghasemi (17 shared papers)Majid Momeny (32 shared papers)Mohammad‐Javad Sanaei (16 shared papers)Kamran Alimoghaddam (17 shared papers)Farkhondeh Asadi (5 shared papers)
- Journals
- European Journal of Pharmacology (14 papers)International Immunopharmacology (11 papers)The International Journal of Biochemistry & Cell Biology (8 papers)Anti-Cancer Drugs (5 papers)IUBMB Life (5 papers)
- Partner nations
- IranFinlandUnited States
In The Last Decade
Davood Bashash
191 papers receiving 3.5k citations
Davood Bashash's Hit Papers
Peers
Comparison fields: 5 of 148
- Cancer Research 457
- Hematology 294
- Immunology 537
- Oncology 659
- Molecular Biology 1.6k
Countries citing papers authored by Davood Bashash
This map shows the geographic impact of Davood Bashash's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Davood Bashash with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Davood Bashash more than expected).
Fields of papers citing papers by Davood Bashash
This network shows the impact of papers produced by Davood Bashash. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Davood Bashash. The network helps show where Davood Bashash may publish in the future.
Co-authors
The 25 scholars most cited alongside Davood Bashash, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 200 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 153 | |
| 2 | 2020 | 138 | |
| 3 | The PI3K/Akt/mTOR pathway in lung cancer; oncogenic alterations, therapeutic opportunities, challenges, and a glance at the application of nanoparticles Hit paper breakdown → | 2022 | 133 |
| 4 | A comprehensive review of highly pathogenic avian influenza (HPAI) H5N1: An imminent threat at doorstep Hit paper breakdown → | 2023 | 99 |
| 5 | 2021 | 94 | |
| 6 | 2021 | 91 | |
| 7 | 2020 | 77 | |
| 8 | 2016 | 75 | |
| 9 | 2021 | 73 | |
| 10 | 2022 | 70 | |
| 11 | 2020 | 63 | |
| 12 | 2021 | 60 | |
| 13 | 2020 | 58 | |
| 14 | 2016 | 49 | |
| 15 | 2019 | 47 | |
| 16 | 2019 | 47 | |
| 17 | 2021 | 45 | |
| 18 | 2011 | 40 | |
| 19 | 2019 | 38 | |
| 20 | 2018 | 38 |
About Davood Bashash
Davood Bashash is a scholar working on Molecular Biology, Oncology, Immunology, Hematology and Cancer Research, having authored 200 papers that have together received 3.6k indexed citations. Recurring topics across this work include Retinoids in leukemia and cellular processes (28 papers), PI3K/AKT/mTOR signaling in cancer (21 papers), Acute Myeloid Leukemia Research (16 papers), COVID-19 Clinical Research Studies (16 papers), Cancer Immunotherapy and Biomarkers (14 papers), Protein Degradation and Inhibitors (11 papers), Immune cells in cancer (11 papers) and Histone Deacetylase Inhibitors Research (10 papers). The work is most often cited by research in Cancer Research (457 citations), Hematology (294 citations), Immunology (537 citations), Oncology (659 citations) and Molecular Biology (1.6k citations). Davood Bashash has collaborated with scholars based in Iran, Finland and United States. Frequent co-authors include Atieh Pourbagheri‐Sigaroodi, Seyed H. Ghaffari, Ava Safaroghli‐Azar, Hassan Abolghasemi, Majid Momeny, Mohammad‐Javad Sanaei, Kamran Alimoghaddam, Farkhondeh Asadi, Zahra Zandi and Mustafa Ghaderzadeh. Their work appears in journals such as European Journal of Pharmacology, International Immunopharmacology, The International Journal of Biochemistry & Cell Biology, Anti-Cancer Drugs and IUBMB Life.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.